Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Neumora Therapeutics, Inc. (NMRA) had Debt to Capital Ratio of 0.54 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-43.08M |
|
-- |
|
-- |
|
$42.19M |
|
$-42.19M |
|
$-0.89M |
|
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-43.08M |
|
$-42.19M |
|
$-41.79M |
|
185.16M |
|
185.16M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$124.87M |
|
$0.03M |
|
$0.38M |
|
$125.25M |
|
$27.78M |
|
$52.91M |
|
$52.95M |
|
$80.73M |
|
$44.52M |
|
$44.52M |
|
$44.52M |
|
186.85M |
|
| Cash Flow Statement Financials | |
$-85.93M |
|
$0.07M |
|
$20.16M |
|
$182.53M |
|
$116.83M |
|
$-65.70M |
|
$14.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.50 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.54 |
1.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-96.77% |
|
-96.77% |
|
-34.40% |
|
-44.22% |
|
$0.24 |
|
$-0.46 |
|
$-0.46 |
|